Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.76 USD | +0.16% | -6.60% | -11.75% |
05-09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
05-08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.75% | 775M | |
+4.54% | 111B | |
+11.14% | 105B | |
-12.28% | 22.34B | |
-3.52% | 21.93B | |
-6.17% | 18.59B | |
-35.21% | 18.12B | |
-9.38% | 16.96B | |
+3.01% | 13.7B | |
+36.28% | 12.45B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- RBC Capital Adjusts REGENXBIO's Price Target to $29 from $47, Maintains Sector Perform Rating